Impaction bone grafting of the acetabulum at hip revision using a mix of bone chips and a biphasic porous ceramic bone graft substitute: Good outcome in 43 patients followed for a mean of 2 years

Background and purpose One of the greatest problems of revision hip arthroplasty is dealing with lost bone stock. Good results have been obtained with impaction grafting of allograft bone. However, there have been problems of infection, reproducibility, antigenicity, stability, availability of bone, and cost. Thus, alternatives to allograft have been sought. BoneSave is a biphasic porous ceramic specifically designed for use in impaction grafting. BoneSave is 80% tricalcium phosphate and 20% hydroxyapatite. Previous in vitro and in vivo studies have yielded good results using mixtures of allograft and BoneSave, when compared with allograft alone. This study is the first reported human clinical trial of BoneSave in impaction grafting

Polymethylmethacrylate extrusion into the femoral nutrient vessel during arthroplasty: A phenomenon to be aware of

Third generation cementing technique is now commonly used for total hip arthroplasty. The aim of this technique is to sufficiently pressurise the cement and allow maximal penetration of the cement into any remaining trabecular bone to provide a stable fixation of the prosthesis. We report a case where this pressurisation resulted in polymethylmethacrylate retrograde filling of the nutrient vessel and we discuss the controversial diagnosis and current literature surrounding this rare phenomenon